
### [MONDO:0016185](http://purl.obolibrary.org/obo/MONDO_0016185)
**Label:** qualitative or quantitative defects of protein O-mannosyltransferase 2

**Subclasses:** [MONDO:0019523](http://purl.obolibrary.org/obo/MONDO_0019523) (Walker-Warburg syndrome), [MONDO:0014683](http://purl.obolibrary.org/obo/MONDO_0014683) (muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 9), 

**Corr. equiv. classes:** [OMIM:253800](http://purl.obolibrary.org/obo/OMIM_253800), [OMIM:615041](http://purl.obolibrary.org/obo/OMIM_615041), [OMIM:615181](http://purl.obolibrary.org/obo/OMIM_615181), [OMIM:615287](http://purl.obolibrary.org/obo/OMIM_615287), [OMIM:613150](http://purl.obolibrary.org/obo/OMIM_613150), [OMIM:613153](http://purl.obolibrary.org/obo/OMIM_613153), [OMIM:613154](http://purl.obolibrary.org/obo/OMIM_613154), [OMIM:253280](http://purl.obolibrary.org/obo/OMIM_253280), [OMIM:616538](http://purl.obolibrary.org/obo/OMIM_616538), [OMIM:614830](http://purl.obolibrary.org/obo/OMIM_614830), [OMIM:614643](http://purl.obolibrary.org/obo/OMIM_614643), [OMIM:615249](http://purl.obolibrary.org/obo/OMIM_615249), [Orphanet:899](http://www.orpha.net/ORDO/Orphanet_899), [Orphanet:370997](http://www.orpha.net/ORDO/Orphanet_370997), 

**Class expressions from DL-Learner:**

- [HP:0003560](http://purl.obolibrary.org/obo/HP_0003560) (Muscular dystrophy) 71.43%
- [HP:0006829](http://purl.obolibrary.org/obo/HP_0006829) (Severe muscular hypotonia) and [HP:0012823](http://purl.obolibrary.org/obo/HP_0012823) (Clinical modifier) and [HP:0040081](http://purl.obolibrary.org/obo/HP_0040081) (Abnormal levels of creatine kinase in blood) 64.29%
- [HP:0006829](http://purl.obolibrary.org/obo/HP_0006829) (Severe muscular hypotonia) and [HP:0012823](http://purl.obolibrary.org/obo/HP_0012823) (Clinical modifier) and [HP:0030724](http://purl.obolibrary.org/obo/HP_0030724) (Central nervous system cyst) 64.29%
- [HP:0006829](http://purl.obolibrary.org/obo/HP_0006829) (Severe muscular hypotonia) and [HP:0011805](http://purl.obolibrary.org/obo/HP_0011805) (Abnormality of muscle morphology) and [HP:0012823](http://purl.obolibrary.org/obo/HP_0012823) (Clinical modifier) 64.29%
- [HP:0006829](http://purl.obolibrary.org/obo/HP_0006829) (Severe muscular hypotonia) and [HP:0011283](http://purl.obolibrary.org/obo/HP_0011283) (Abnormality of the metencephalon) and [HP:0012823](http://purl.obolibrary.org/obo/HP_0012823) (Clinical modifier) 64.29%
- [HP:0006829](http://purl.obolibrary.org/obo/HP_0006829) (Severe muscular hypotonia) and [HP:0011282](http://purl.obolibrary.org/obo/HP_0011282) (Abnormality of hindbrain morphology) and [HP:0012823](http://purl.obolibrary.org/obo/HP_0012823) (Clinical modifier) 64.29%
- [HP:0006829](http://purl.obolibrary.org/obo/HP_0006829) (Severe muscular hypotonia) and [HP:0011021](http://purl.obolibrary.org/obo/HP_0011021) (Abnormality of circulating enzyme level) and [HP:0012823](http://purl.obolibrary.org/obo/HP_0012823) (Clinical modifier) 64.29%
- [HP:0006829](http://purl.obolibrary.org/obo/HP_0006829) (Severe muscular hypotonia) and [HP:0010876](http://purl.obolibrary.org/obo/HP_0010876) (Abnormality of circulating protein level) and [HP:0012823](http://purl.obolibrary.org/obo/HP_0012823) (Clinical modifier) 64.29%
- [HP:0006829](http://purl.obolibrary.org/obo/HP_0006829) (Severe muscular hypotonia) and [HP:0010576](http://purl.obolibrary.org/obo/HP_0010576) (Intracranial cystic lesion) and [HP:0012823](http://purl.obolibrary.org/obo/HP_0012823) (Clinical modifier) 64.29%
- [HP:0006829](http://purl.obolibrary.org/obo/HP_0006829) (Severe muscular hypotonia) and [HP:0007362](http://purl.obolibrary.org/obo/HP_0007362) (Aplasia/Hypoplasia of the brainstem) and [HP:0012823](http://purl.obolibrary.org/obo/HP_0012823) (Clinical modifier) 64.29%
- [HP:0004328](http://purl.obolibrary.org/obo/HP_0004328) (Abnormality of the anterior segment of the globe) and [HP:0006829](http://purl.obolibrary.org/obo/HP_0006829) (Severe muscular hypotonia) and [HP:0012823](http://purl.obolibrary.org/obo/HP_0012823) (Clinical modifier) 64.29%
- [HP:0003560](http://purl.obolibrary.org/obo/HP_0003560) (Muscular dystrophy) and [HP:0006829](http://purl.obolibrary.org/obo/HP_0006829) (Severe muscular hypotonia) and [HP:0012823](http://purl.obolibrary.org/obo/HP_0012823) (Clinical modifier) 64.29%
- [HP:0003236](http://purl.obolibrary.org/obo/HP_0003236) (Elevated serum creatine phosphokinase) and [HP:0006829](http://purl.obolibrary.org/obo/HP_0006829) (Severe muscular hypotonia) and [HP:0012823](http://purl.obolibrary.org/obo/HP_0012823) (Clinical modifier) 64.29%
- [HP:0002538](http://purl.obolibrary.org/obo/HP_0002538) (Abnormality of the cerebral cortex) and [HP:0006829](http://purl.obolibrary.org/obo/HP_0006829) (Severe muscular hypotonia) and [HP:0012823](http://purl.obolibrary.org/obo/HP_0012823) (Clinical modifier) 64.29%
- [HP:0002536](http://purl.obolibrary.org/obo/HP_0002536) (Abnormal cortical gyration) and [HP:0006829](http://purl.obolibrary.org/obo/HP_0006829) (Severe muscular hypotonia) and [HP:0012823](http://purl.obolibrary.org/obo/HP_0012823) (Clinical modifier) 64.29%


